BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
BillionToOne, Inc.NASDAQ: BLLN
Total Equity · Q2 FY2026 · quarter ended Jun 2026
Total equity rises 217.3% from a year ago
Total equity stood at $536.81M at the end of Q2 FY2026, up 217.3% from a year earlier and up 6.2% from the prior quarter.
Context
- Total equity amounted to 73.6% of total assets at the end of Q2 FY2026, up 19.5 pp from a year earlier.
- Total equity increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +217.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 480.11M USD
- Year-over-year change
- +186.2%
- 2-year CAGR
- +296.9%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 480.11M | +186.2% |
| FY2024 | 2024-12-31 | 167.75M | +450.5% |
| FY2023 | 2023-12-31 | 30.47M | — |
Total Equity vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 total equity of $536.81M is the 6th highest of the 9 companies compared; the peer median is $914.94M.
- Its year-over-year change of +217.3% is the highest of 9, against a peer median of +1.4%.
- Total equity amounts to 73.6% of total assets for BLLN, versus a peer median of 63.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $2.54B | +9.9% | -17.8% | 89.4% | |
| Jun 2026 | $1.82B | +46.2% | +34.4% | 68.5% | |
| Jun 2026 | $1.39B | +13.7% | +6.8% | 93.4% | |
| Mar 2026 | $1.04B | -7.0% | -4.5% | 90.3% | |
| Jun 2026 | $785.73M | -8.0% | -5.7% | 58.1% | |
BLLNBillionToOne, Inc. | Jun 2026 | $536.81M | +217.3% | — | 73.6% |
| Mar 2026 | $337.4M | -52.1% | -25.4% | 50.1% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $244.22M | -11.9% | +6.7% | 50.7% |
| Sep 2026 | -$275.9M | +22.2% | — | 14.6% | |
| Peer median (excluding BLLN) | $914.94M | +1.4% | -4.5% | 63.3% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.